Page 77 - SAMRC Annual Performance Plan 2026-27

Table 37. Programme 2 continued

INDICATOR TITLE 2.3.1 Number of research grants funded by the SAMRC
Total number of research grants funded by the SAMRC. This includes
DEFINITION new and ongoing grants that received funding during the reporting
period

SOURCE OF DATA GIPD/SHIP/RCD and other relevant internal departments
Count the number of research grants funded by the SAMRC during
METHOD OF CALCULATION/ASSESSMENT
the reporting period
ASSUMPTIONS The evidence presented to the auditors is reliable, relevant and valid

REPORTING CYCLE Annually
DESIRED PERFORMANCE To achieve set target for the reporting period

INDICATOR RESPONSIBILITY Executive Director: Grants Innovation and Product Development

Table 38. Programme 3

3.1.1 Number of innovation and technology projects funded by the
INDICATOR TITLE SAMRC aimed at developing, testing and/or implementing new
or improved health solutions
Total number of innovation and technology projects funded by the
SAMRC that are aimed at developing, testing and/or implementing
new or improved health solutions, such as, but not limited to, new
diagnostics, vaccines, drugs, e-health interventions, medical devices
DEFINITION and treatment regimens. This includes new and ongoing innovation
and technology projects that received funding during the reporting
period and those that did not receive a funding disbursement during
the reporting period but continued to be executed using funding
previously disbursed by the SAMRC for that purpose.

SOURCE OF DATA Grants Innovation and Product Development (GIPD)
Count the number of innovation and technology projects funded by
METHOD OF CALCULATION/ASSESSMENT
the SAMRC during the reporting period
ASSUMPTIONS The evidence presented to the auditors is reliable, relevant and valid
REPORTING CYCLE Annual
DESIRED PERFORMANCE To achieve set target for the reporting period

INDICATOR RESPONSIBILITY Executive Director: Grants Innovation and Product Development

SAMRC ANNUAL PERFORMANCE PLAN 2026/27 75